Bumper Dividend Alert! Multibagger Pharma Stock With 48% ROE Announces 300% Dividend; Check Record Date

Dividend Stock: Shares of pharmaceutical company RPG Life Sciences were trading higher on Thursday as the small-cap pharma stock enjoys investors' attention because of its dividend announcement. The company has announced a 300% dividend for its shareholders and fixed the record date.

RPG Life Sciences shares closed 5.54% higher at Rs 2385.55 per share on BSE on Thursaday. The company scrip touched an intraday high mark of Rs 2439.85 per share on BSE on Thursday.

RPG Life Sciences Dividend

The pharmaceutical sector stock in June announced a final dividend, along with a special dividend for its eligible shareholders. A dividend is a part of the company's profit that it is willing to distribute among its shareholders.

RPG Life Sciences Board had recommended the "Payment of final dividend of Rs. 20 and additionally a special dividend of Rs. 4 aggregating to Rs.24 per Equity share of Rs.8 each of the Company for the financial year ended March 31, 2025, subject to approval by the shareholders at the ensuing AGM to be held on Wednesday, July 16, 2025." The company had also announced dividend record date to find the eligibility of shareholders.

RPG Life Sciences Dividend Record Date

RPG Life Sciences' dividend record date is fixed for next week. Before its record date, the company's stock had witnessed heightened interest among investors. The company has fixed June 27 as the dividend record date.

"Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, June 27, 2025, as the Record Date for determining entitlement of Members to receive the aforesaid dividend, if approved by the shareholders at the AGM," read the BSE filing by RPG Life Sciences.

RPG Life Sciences Share Price Trend

The company stock ended in green at Rs 2385.55 per share with a market capitalisation of Rs 3,945.46 crore. The company scrip is trading close to its 52-week high mark of Rs 2,976.70 per share which it touched on Rs 15 October 2024. The company stock touched its 52-week low mark of Rs 1,457.00 on 24 June, 2024.

RPG Life Sciences' stock value has increased nearly 53.71% in one year, and has surged by around 161.5% in two years, and by a whopping 364% in three years. The stock has an ROE of 48.30.

The Mumbai-headquartered RPG Life Sciences is an integrated pharmaceutical company which has a strong presence not only in India but across international markets in the branded formulations, global generics and synthetic APIs space.

Earlier known as Searle India Ltd, RPG Life Sciences was formed in 1968. The company came into existence as a joint venture with GD Searle in the USA. Later, Searle withdrew its stake from the RPG group and later the entity was renamed as RPG Life Sciences.

Its parent firm, RPG Enterprises owns nearly 15 companies with a strong presence in sectors like infrastructure, tyres, IT, pharmaceuticals, energy and plantations. According to the company website, it is the fastest growing business groups with a turnover in excess of Rs 23,000 crore.